Capital Fund Management (CFM)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Capital Fund Management (CFM)'s NVO Position: Q2 2026 in Review
Capital Fund Management (CFM) sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 549,373 shares — an estimated $23.6M sold.
Capital Fund Management (CFM) first reported a position in NVO in Q2 2013 and held it in 41 quarters. The position peaked at $98.7M in Q1 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Capital Fund Management (CFM) reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Capital Fund Management (CFM) sold 549,373 Novo Nordisk shares in Q2 2026, an estimated $23.6M.
- Capital Fund Management (CFM) first reported a position in Novo Nordisk in Q2 2013 and held it in 41 quarters.
- Capital Fund Management (CFM)'s Novo Nordisk position peaked at $98.7M in Q1 2024.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.